Pharmacology
Sort by:
Mount Sinai Advanced Innovations in Heart Failure
Management of Atrial Fibrillation in Heart Failure: EAST-AFNET4, CABANA Trial and RAFT-AF Trials
FEATURING
Vivek Reddy
- 1,712 views
- March 2, 2022
- 9
Texas Cardiovascular Innovations Conference 2021
Atrial Fibrillation / Flutter: Who Needs Ablation?
FEATURING
David Pederson
- 1,024 views
- March 2, 2022
- 7
Texas Cardiovascular Innovations Conference 2021
Complex Coronary Interventions: Drugs, Devices and Durability
FEATURING
Jasvindar Singh
- 548 views
- March 2, 2022
- 4
Miami Valves 2022
Sudden Cardiac Arrest in Young Adults
FEATURING
Robert Myerburg
- 530 views
- February 28, 2022
- 1
Miami Valves 2022
LAA Closure: New Trials and Advances
FEATURING
Ignacio Cruz-Gonzalez
- 38 views
- February 25, 2022
American College of Cardiology
ESC Congress 2021: TWILIGHT-HBR, The Michelle Trial, ECLA PHRI COLCOVID and PREPARE-IT Trials
FEATURING
Deepak Bhatt,
Philippe Gabriel Steg
- 335 views
- February 15, 2022
- 1
American College of Cardiology
ESC Congress 2021: MASTER DAPT, ENVISAGE-TAVI AF and FIGARO-DKD Trials
FEATURING
Deepak Bhatt,
Philippe Gabriel Steg
- 16 views
- February 15, 2022
American College of Cardiology
TCT 2021 Highlights: PRAGUE-17 and STOPDAPT-2 Trials
- 12 views
- February 15, 2022
American College of Cardiology
MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High Bleeding Risk
- 196 views
- February 15, 2022
- 2
American College of Cardiology
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI
FEATURING
Valentin Fuster,
Dipti Itchhaporia
- 13 views
- February 15, 2022
American College of Cardiology
EAST-AFNET 4: Early Rhythm-Control Therapy in Patients With Atrial Fibrillation
- 224 views
- February 15, 2022
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation - in Defense of Digoxin
FEATURING
John Mandrola
- 1,887 views
- February 8, 2022
- 15
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation
FEATURING
Michelle Kittleson
- 1,319 views
- February 8, 2022
- 11
Cedars Sinai
Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical Therapy Is King (and Queen)
FEATURING
William Boden
- 3,406 views
- February 4, 2022
- 18
University of Colorado Department of Medicine
Frontiers and Advances in Arrhythmia Management
FEATURING
Wendy Tzou
- 1,308 views
- February 2, 2022
- 11
Houston Methodist DeBakey Heart and Vascular Center
Aspirin: Not a "Wonder Drug" Anymore?
FEATURING
Miguel Cainzos-Achirica
- 433 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy
FEATURING
Jose Ferreiro
- 162 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Plaque Burden Is the Main Driver of Risk for Atherosclerotic Events: Beyond Coronary Stenosis
FEATURING
Martin Mortensen
- 253 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Aspirin & Primary Prevention: What Do the Guidelines Say?
FEATURING
Martha Gulati
- 3,160 views
- January 25, 2022
- 13
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What Changed?
FEATURING
Michael Miedema
- 3,371 views
- January 25, 2022
- 24
Houston Methodist DeBakey Heart and Vascular Center
CAC Score for Aspirin Allocation
FEATURING
Miguel Cainzos-Achirica
- 388 views
- January 25, 2022
- 2
The Ludeman Family Center for Women’s Health Research
Sex Differences in Cardiac Arrhythmias
FEATURING
Wendy Tzou
- 11 views
- January 24, 2022
New York Transcatheter Valves 2021
Pharmacology in TAVR: State of the Art
FEATURING
George Dangas
- 369 views
- January 21, 2022
- 3